HK1086819A1 - 2-(butyl-1-sulfonylamino)-n-(1(r)-(6-methoxy-pyridin-3-yl)-propyl)-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound - Google Patents
2-(butyl-1-sulfonylamino)-n-(1(r)-(6-methoxy-pyridin-3-yl)-propyl)-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compoundInfo
- Publication number
- HK1086819A1 HK1086819A1 HK06106891A HK06106891A HK1086819A1 HK 1086819 A1 HK1086819 A1 HK 1086819A1 HK 06106891 A HK06106891 A HK 06106891A HK 06106891 A HK06106891 A HK 06106891A HK 1086819 A1 HK1086819 A1 HK 1086819A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- benzamid
- sulfonylamino
- pyridin
- methoxy
- propyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10312073A DE10312073A1 (de) | 2003-03-18 | 2003-03-18 | 2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxy-pyridin-3yl)-propyl]-benzamid, dessen Verwendung als Medikament sowie dieses enthaltende pharmazeutische Zubereitungen |
PCT/EP2004/002247 WO2004083157A1 (de) | 2003-03-18 | 2004-03-05 | 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, dessen verwendung als medikament sowie dieses enthaltende pharmazeutische zubereitungen |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1086819A1 true HK1086819A1 (en) | 2006-09-29 |
Family
ID=32920928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06106891A HK1086819A1 (en) | 2003-03-18 | 2006-06-16 | 2-(butyl-1-sulfonylamino)-n-(1(r)-(6-methoxy-pyridin-3-yl)-propyl)-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1606237A1 (sr) |
JP (1) | JP2006520343A (sr) |
KR (1) | KR20050110681A (sr) |
CN (1) | CN100361943C (sr) |
AR (1) | AR043622A1 (sr) |
AU (1) | AU2004222137A1 (sr) |
BR (1) | BRPI0408441A (sr) |
CA (1) | CA2519022A1 (sr) |
DE (1) | DE10312073A1 (sr) |
HK (1) | HK1086819A1 (sr) |
HR (1) | HRP20050815A2 (sr) |
MA (1) | MA27749A1 (sr) |
MX (1) | MXPA05009763A (sr) |
MY (1) | MY176510A (sr) |
NO (1) | NO20054472L (sr) |
NZ (1) | NZ542476A (sr) |
PE (1) | PE20050307A1 (sr) |
RS (1) | RS20050690A (sr) |
RU (1) | RU2333202C2 (sr) |
TW (1) | TW200500342A (sr) |
WO (1) | WO2004083157A1 (sr) |
ZA (1) | ZA200506328B (sr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004009931A1 (de) * | 2004-02-26 | 2005-09-15 | Aventis Pharma Deutschland Gmbh | Kv1.5-Blocker zur selektiven Steigerung der Vorhofkontraktilität und Behandlung der Herzinsuffizienz |
US7569589B2 (en) | 2004-07-29 | 2009-08-04 | Merck & Co., Inc. | Potassium channel inhibitors |
DE102005028845A1 (de) * | 2005-06-22 | 2006-12-28 | Sanofi-Aventis Deutschland Gmbh | Substituierte Heterocyclen, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen |
WO2007015775A2 (en) * | 2005-07-22 | 2007-02-08 | Merck & Co., Inc. | Potassium channel inhibitors |
JP5685203B2 (ja) | 2009-05-29 | 2015-03-18 | ラクオリア創薬株式会社 | カルシウムチャネル遮断薬またはナトリウムチャネル遮断薬としてのアリール置換カルボキサミド誘導体 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10121003A1 (de) * | 2001-04-28 | 2002-12-19 | Aventis Pharma Gmbh | Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
-
2003
- 2003-03-18 DE DE10312073A patent/DE10312073A1/de not_active Withdrawn
-
2004
- 2004-03-05 CA CA002519022A patent/CA2519022A1/en not_active Abandoned
- 2004-03-05 EP EP04717628A patent/EP1606237A1/de not_active Withdrawn
- 2004-03-05 KR KR1020057017498A patent/KR20050110681A/ko not_active Application Discontinuation
- 2004-03-05 RS YUP-2005/0690A patent/RS20050690A/sr unknown
- 2004-03-05 AU AU2004222137A patent/AU2004222137A1/en not_active Abandoned
- 2004-03-05 JP JP2006504553A patent/JP2006520343A/ja not_active Abandoned
- 2004-03-05 RU RU2005132163/04A patent/RU2333202C2/ru not_active IP Right Cessation
- 2004-03-05 NZ NZ542476A patent/NZ542476A/en unknown
- 2004-03-05 PE PE2004000245A patent/PE20050307A1/es not_active Application Discontinuation
- 2004-03-05 MX MXPA05009763A patent/MXPA05009763A/es active IP Right Grant
- 2004-03-05 WO PCT/EP2004/002247 patent/WO2004083157A1/de active Application Filing
- 2004-03-05 BR BRPI0408441-1A patent/BRPI0408441A/pt not_active IP Right Cessation
- 2004-03-05 CN CNB2004800060168A patent/CN100361943C/zh not_active Expired - Fee Related
- 2004-03-16 AR ARP040100866A patent/AR043622A1/es unknown
- 2004-03-16 TW TW093106899A patent/TW200500342A/zh unknown
- 2004-03-17 MY MYPI20040938A patent/MY176510A/en unknown
-
2005
- 2005-08-08 ZA ZA200506328A patent/ZA200506328B/en unknown
- 2005-09-16 HR HR20050815A patent/HRP20050815A2/xx not_active Application Discontinuation
- 2005-09-19 MA MA28502A patent/MA27749A1/fr unknown
- 2005-09-27 NO NO20054472A patent/NO20054472L/no not_active Application Discontinuation
-
2006
- 2006-06-16 HK HK06106891A patent/HK1086819A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO20054472L (no) | 2005-09-27 |
MY176510A (en) | 2020-08-12 |
RU2005132163A (ru) | 2006-04-10 |
DE10312073A1 (de) | 2004-09-30 |
PE20050307A1 (es) | 2005-06-08 |
CN1756728A (zh) | 2006-04-05 |
CN100361943C (zh) | 2008-01-16 |
NZ542476A (en) | 2008-05-30 |
KR20050110681A (ko) | 2005-11-23 |
TW200500342A (en) | 2005-01-01 |
ZA200506328B (en) | 2006-04-26 |
CA2519022A1 (en) | 2004-09-30 |
HRP20050815A2 (en) | 2006-09-30 |
RU2333202C2 (ru) | 2008-09-10 |
EP1606237A1 (de) | 2005-12-21 |
AR043622A1 (es) | 2005-08-03 |
MXPA05009763A (es) | 2006-01-27 |
AU2004222137A1 (en) | 2004-09-30 |
BRPI0408441A (pt) | 2006-04-04 |
RS20050690A (sr) | 2008-04-04 |
JP2006520343A (ja) | 2006-09-07 |
WO2004083157A1 (de) | 2004-09-30 |
MA27749A1 (fr) | 2006-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0700086A2 (en) | 2-aminopyridine compounds, use thereof as drugs and pharmaceutical compositions containing them | |
HUP0402236A3 (en) | Heterocyclic compounds pharmaceutical compounds containing thereof and use thereof | |
IL207028A0 (en) | Pharmaceutical nati-tnf-alpha antibody formulation | |
IL156716A0 (en) | Pharmaceutical formulation | |
ATE307571T1 (de) | Pharmazeutische formulierung enthaltend bicalutamid | |
EG24078A (en) | Liquid pharmaceutical composition | |
GB0118689D0 (en) | Pharmaceutical formulation | |
HUP0401638A3 (en) | Thiopene-amides, thiazolesulfonamides as antineoplastic agents, and pharmaceutical composition containing the same | |
HK1129111A1 (en) | Tiotropium salts, pharmaceutical formulations containing the salts and the use thereof | |
EP1619180A4 (en) | CASR ANTAGONIST | |
PL366432A1 (en) | Pharmaceutical formulation | |
HUP0401747A3 (en) | Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds | |
HK1096960A1 (en) | Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h- chromium-6-yl-derivatives and drugs containing said compounds | |
PL394600A1 (pl) | Związek winyloazacykloalkanowy, sposób jego wytwarzania i jego zastosowanie oraz kompozycja farmaceutyczna | |
ATE324883T1 (de) | Pharmazeutische zusammensetzung enthaltend lumiracoxib | |
HK1086819A1 (en) | 2-(butyl-1-sulfonylamino)-n-(1(r)-(6-methoxy-pyridin-3-yl)-propyl)-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound | |
ATE350016T1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung | |
HUP0401862A3 (en) | Novel heterocyclic compound and medicinal use thereof and pharmaceutical compositions containing them | |
IL158587A0 (en) | Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof | |
ATE350029T1 (de) | Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain | |
AU2003294952A8 (en) | 3,3-dimethyl-8-oxoisoquinolines for medical purposes, methods for the production thereof, medicaments containing said compounds and the use of the same | |
IL152751A0 (en) | Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them | |
ITMI20011457A0 (it) | Composizione farmaceutica a rilascio modificato contenente bupropionehc1 come sostanza attiva | |
HUP0201992A3 (en) | Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing the compounds and their use | |
GB0104749D0 (en) | Pharmaceutical formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20120305 |